1. Home
  2. CTMX vs MGRM Comparison

CTMX vs MGRM Comparison

Compare CTMX & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • MGRM
  • Stock Information
  • Founded
  • CTMX 2008
  • MGRM 2016
  • Country
  • CTMX United States
  • MGRM United States
  • Employees
  • CTMX N/A
  • MGRM N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • MGRM Medical/Dental Instruments
  • Sector
  • CTMX Health Care
  • MGRM Health Care
  • Exchange
  • CTMX Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • CTMX 85.3M
  • MGRM 89.6M
  • IPO Year
  • CTMX 2015
  • MGRM N/A
  • Fundamental
  • Price
  • CTMX $0.83
  • MGRM $2.69
  • Analyst Decision
  • CTMX Buy
  • MGRM Strong Buy
  • Analyst Count
  • CTMX 6
  • MGRM 1
  • Target Price
  • CTMX $5.77
  • MGRM $4.00
  • AVG Volume (30 Days)
  • CTMX 785.3K
  • MGRM 33.3K
  • Earning Date
  • CTMX 03-10-2025
  • MGRM 03-14-2025
  • Dividend Yield
  • CTMX N/A
  • MGRM N/A
  • EPS Growth
  • CTMX N/A
  • MGRM N/A
  • EPS
  • CTMX 0.16
  • MGRM N/A
  • Revenue
  • CTMX $126,617,000.00
  • MGRM $364,999.00
  • Revenue This Year
  • CTMX $22.55
  • MGRM N/A
  • Revenue Next Year
  • CTMX N/A
  • MGRM N/A
  • P/E Ratio
  • CTMX $4.97
  • MGRM N/A
  • Revenue Growth
  • CTMX 33.66
  • MGRM N/A
  • 52 Week Low
  • CTMX $0.75
  • MGRM $1.53
  • 52 Week High
  • CTMX $5.85
  • MGRM $4.90
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 44.23
  • MGRM 49.40
  • Support Level
  • CTMX $0.75
  • MGRM $2.66
  • Resistance Level
  • CTMX $0.98
  • MGRM $2.85
  • Average True Range (ATR)
  • CTMX 0.06
  • MGRM 0.13
  • MACD
  • CTMX 0.00
  • MGRM -0.02
  • Stochastic Oscillator
  • CTMX 33.17
  • MGRM 36.36

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: